- Home>
- Journal Watch
- >
- bone mass measurement
Search for bone mass measurement in all Journal Watch editions
Physician-authored summaries on the latest research on bone mass measurement, editorials on bone mass measurement, and perspectives on bone mass measurement - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 290 results - Relevance
- Date
You searched for: bone mass measurement
-
Lactose Malabsorption in Children Is Not Associated with Lower Calcium Intake or Bone Mass
- February 22, 2012
- Cornelius W. Van Niel, MD
- Pediatrics and Adolescent Medicine
Lactose absorbers and malabsorbers have the same calcium intake and bone density.- Reviewing:
- da Silva Medeiros LC et al., J Pediatr Gastroenterol Nutr 2012 Feb; 54:204.
-
Intravenous Bisphosphonate Therapy for Postmenopausal Women with Low Bone Mass
- November 19, 2009
- Andrew M. Kaunitz, MD
- Women's Health
IV zoledronic acid prevented bone loss.- Reviewing:
- McClung M et al., Obstet Gynecol 2009 Nov; 114:999.
-
Depression and Low Bone Mass Free
- December 18, 2007
- Jamaluddin Moloo, MD, MPH
- General Medicine
Depressed women had lower BMD and higher levels of several proinflammatory markers.- Reviewing:
- Eskandari F et al., Arch Intern Med 2007 Nov 26; 167:2329.
-
Bone Mass During and After Depomedroxyprogesterone Acetate Contraceptive Injections
- October 5, 2006
- Ann J. Davis, MD
- Women's Health
These findings provide more evidence that lost bone mass is regained after DMPA discontinuation.- Reviewing:
- Kaunitz AM et al., Contraception 2006 Aug; 74:90-9.
-
Maintaining Bone Mass in Premenopausal Breast Cancer Patients: How Effective Is Zoledronic Acid?
- September 25, 2008
- Andrew M. Kaunitz, MD
- Women's Health
IV bisphosphonate provided long-term protection against BMD loss in premenopausal women receiving adjuvant endocrine therapy.- Reviewing:
- Gnant M et al., Lancet Oncol 2008 Sep; 9:840.
-
Maternal Vitamin D Status and Childhood Bone Density
- February 7, 2006
- Bruce Soloway, MD
- General Medicine
Vitamin D supplementation during pregnancy might increase a child’s bone mass.- Reviewing:
- Javaid MK et al., Lancet 2006 Jan 7; 367:36-43.
-
The Achilles Heel of Chemoprevention: Bone Health?
- March 6, 2012
- William J. Gradishar, MD
- Oncology and Hematology
Bone-mineral density loss was greater in postmenopausal women receiving the aromatase inhibitor exemestane than in those receiving placebo.- Reviewing:
- Cheung AM et al., Lancet Oncol 2012 Mar; 13:275.
-
When Should Bone-Density Tests Be Repeated? Free
- January 24, 2012
- Allan S. Brett, MD
- General Medicine
A 15-year interval is reasonable in older women if baseline BMD is normal or only mildly osteopenic.
CME Exam- Reviewing:
- Gourlay ML et al., N Engl J Med 2012 Jan 19; 366:225.
-
All Common Thymidine-Sparing Regimens Induce Early Bone Loss
- June 20, 2011
- Abigail Zuger, MD
- HIV/AIDS
The greatest losses were seen with the combination of tenofovir/FTC + ritonavir-boosted atazanavir.- Reviewing:
- McComsey GA et al., J Infect Dis 2011 Jun 15; 203:1791.
-
Primary Sclerosing Cholangitis and Bone Disease
- February 25, 2011
- Atif Zaman, MD, MPH
- Gastroenterology
Age, body-mass index, and duration of inflammatory bowel disease were risk factors for osteoporosis in patients with PSC.
CME Exam- Reviewing:
- Angulo P et al., Gastroenterology 2011 Jan; 140:180.
-
Changes in Bone-Mineral Density: Abacavir/3TC vs. Tenofovir/FTC
- October 18, 2010
- Paul E. Sax, MD
- HIV/AIDS
In a randomized clinical trial, both treatments reduced BMD, but tenofovir/FTC exerted a more pronounced effect.- Reviewing:
- Stellbrink H-J et al., Clin Infect Dis 2010 Oct 15; 51:963. Carr A and Hoy J., Clin Infect Dis 2010 Oct 15; 51:973.
-
Long-Term Growth and Bone Mineralization in Preterm Children
- November 19, 2008
- William P. Kanto, Jr., MD
- Pediatrics and Adolescent Medicine
Low bone mineralization persists up to age 9 years in children who were born preterm with low birth weight.- Reviewing:
- Chan GM et al., J Perinatol 2008 Sep; 28:619.
-
Predictors of Bone Loss in HIV-Infected Patients
- November 10, 2008
- Paul E. Sax, MD
- HIV/AIDS
Tenofovir and ddI use were each associated with accelerated loss of bone mineral density over time; weight training was protective against loss.- Reviewing:
- Jacobson DL et al., J Acquir Immune Defic Syndr 2008 Nov; 49:298.
-
Weight Control and Bone Density During the Menopausal Transition Free
- October 30, 2007
- Robert W. Rebar, MD
- General Medicine
A healthful diet and exercise program has a downside: loss in BMD.- Reviewing:
- Park HA et al., J Clin Endocrinol Metab 2007 Oct; 92:3809.
-
Alendronate’s Effect on Bone Loss in Men Treated with Hormonal Therapy for Prostate Cancer Free
- April 2, 2007
- Robert Dreicer, MD, MS, FACP
- Oncology and Hematology
Compared with placebo, an oral bisphosphonate significantly improved BMD and lessened bone turnover in men who were receiving ADT.- Reviewing:
- Greenspan SL et al., Ann Intern Med 2007 Mar 20; 146:416-24.
-
Alendronate for Bone Loss Associated with Primary Biliary Cirrhosis
- October 25, 2005
- Atif Zaman, MD, MPH
- Gastroenterology
Decreased bone mass is common among patients with primary biliary cirrhosis (PBC) and can lead to devastating complications in the pre- and post-transplant setting. The . . .- Reviewing:
- Zein CO et al., Hepatology 2005 Oct; 42:762-71.
-
Hormonal Contraception and Bone Health
- February 16, 2012
- Michelle Isley, MD, MPH
- Women's Health
Benefits outweigh safety concerns. -
Chipping Away at Bone: Proton-Pump Inhibitors and Smoking
- February 14, 2012
- Paul S. Mueller, MD, MPH, FACP
- General Medicine
Long-term PPI use was associated with excess risk for postmenopausal hip fractures, especially in smokers.
CME Exam- Reviewing:
- Khalili H et al., BMJ 2012 Jan 31; 344:e372.
-
Raltegravir for Bone Health? Or Just Lose the PI?
- December 12, 2011
- Abigail Zuger, MD
- HIV/AIDS
One year after switching from boosted protease inhibitors to raltegravir, patients had significant improvement in some bone-mineral density measurements.- Reviewing:
- Curran A et al., AIDS 2011 Nov 22;:
-
Diminished Bone Health Is Associated with Psychoses Free
- October 18, 2010
- Joel Yager, MD
- Psychiatry
But some factors contributing to skeletal fragility in patients with psychosis may be reversible.- Reviewing:
- Partti K et al., Psychosom Med 2010 Sep 14;:
Sort by:
Items 1 to 20 of 290 results - Relevance
- Date
